AI assistant
Sending…
BIOGEN INC. — Director's Dealing 2013
Apr 3, 2013
30291_dirs_2013-04-03_9d6827ec-b800-473a-a431-437484865bc1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2013-04-01
Reporting Person: SCANGOS GEORGE A (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-04-01 | Common Stock | S | 1598 | $193.66 | Disposed | 52107 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5378 | Indirect |
| Common Stock | 5378 | Indirect |
Footnotes
F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: This amendment is being filed solely to file the power of attorney as an exhibit. No changes have been made to the transactions reported by the reporting person in his Form 4 filed with the SEC on April 2, 2013.
More from BIOGEN INC.
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Apr 7
Regulatory Filings
2026
Apr 6